PRODUCTION OF A FORM-SPECIFIC, INHIBITORY ANTIBODY AGAINST RAT CYTOCHROME-P450 2B1 USING A SYNTHETIC PEPTIDE ANTIGEN AGAINST A PUTATIVE SUBSTRATE-BINDING SITE
J. Charnecki et al., PRODUCTION OF A FORM-SPECIFIC, INHIBITORY ANTIBODY AGAINST RAT CYTOCHROME-P450 2B1 USING A SYNTHETIC PEPTIDE ANTIGEN AGAINST A PUTATIVE SUBSTRATE-BINDING SITE, Biochemical and biophysical research communications, 216(3), 1995, pp. 1024-1033
Rat cytochrome P450 2B1 antipeptide antibodies were produced by immuni
zing rabbits with a synthetic peptide antigen. The anti-CYP2B1 IgG obt
ained did not cross-react with CYP2B2, which has 97% identity in prima
ry sequence of CYP2B1. This result demonstrates that a difference of 2
amino acid residues among 12 is sufficient to produce a form-specific
antibody. The CYP2B1 antipeptide IgG inhibited pentoxyresorufin O-dea
lkylase activity of microsomes obtained from phenobarbital-treated rat
s in a dose-dependent manner, whereas it did not inhibit ethoxyresoruf
in O-deethylase activity of microsomes obtained from 3-methylcholanthr
ene-treated rats. These results suggest that the selected amino acid s
equence, which coincides with one of the substrate binding sites of Ps
eudomonas putida CYP101A (P450cam) and one of the putative substrate b
inding sites of CYP2B2, is located on the surface of the CYP2B1 molecu
le, as opposed to inside the molecule or in the lipid bilayer of micro
somes. (C) 1995 Academic Press, Inc.